openPR Logo
Press release

Managing Parkinson's: Drug Pipeline Landscape (2023-2033)

12-19-2023 07:57 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Global Insight Services

Managing Parkinson's: Drug Pipeline Landscape (2023-2033)

Market Outlook:

The Parkinson's Disease drug pipeline landscape is entering a phase of significant progress, offering a positive outlook for individuals grappling with this neurodegenerative disorder. As the global incidence of Parkinson's Disease continues to rise, the market anticipates a surge in research and development activities focused on novel therapeutic interventions. The market outlook is characterized by a growing recognition of the need for innovative drugs to address the complex and varied symptoms of Parkinson's Disease. With advancements in understanding the underlying pathophysiology, the drug pipeline landscape holds promise for transformative treatments that can enhance the quality of life for individuals affected by Parkinson's.

Request the sample copy of report @

Market Drivers:

Several key drivers propel the Parkinson's Disease drug pipeline forward. The aging population demographic serves as a primary driver, with an increased prevalence of Parkinson's Disease among the elderly. Advances in neurobiology and a deeper understanding of the molecular mechanisms underlying the disease fuel research initiatives, driving the development of targeted and disease-modifying drug candidates. Additionally, regulatory support and expedited approval pathways for breakthrough therapies contribute to the momentum, encouraging pharmaceutical entities to invest in innovative treatments for Parkinson's Disease.

Market Challenges:

Despite the positive outlook, the Parkinson's Disease drug development faces notable challenges. The heterogeneous nature of Parkinson's Disease, with diverse clinical manifestations and disease progressions, poses hurdles in developing universally effective treatments. Striking a balance between alleviating symptoms and addressing the underlying neurodegenerative processes requires a nuanced approach. Navigating the intricate regulatory landscape and addressing safety concerns demand meticulous attention, adding complexity to the drug development and approval processes.

For In-Depth Competitive Analysis, Buy Now @

Growth Factors:

Several growth factors contribute to the evolution of the Parkinson's Disease drug pipeline landscape. Advances in genetics, genomics, and precision medicine empower researchers to identify and target specific pathways implicated in Parkinson's Disease, fostering the development of more personalized and effective drug therapies. Collaborations between pharmaceutical companies, academic institutions, and research organizations play a pivotal role in pooling expertise and resources, accelerating the pace of drug discovery. Furthermore, a growing emphasis on patient-centric approaches and holistic Parkinson's management shapes the trajectory of the market, recognizing the diverse needs and experiences of individuals affected by this neurodegenerative condition.

In conclusion, the Parkinson's Disease drug pipeline landscape holds great promise, driven by a convergence of market drivers and growth factors. The collective efforts of the scientific community, coupled with a heightened understanding of Parkinson's Disease pathophysiology, position the market for transformative developments in Parkinson's therapeutics. As research progresses and innovative treatments move through the pipeline, the landscape is poised to witness a paradigm shift, offering renewed hope for individuals and families affected by Parkinson's Disease.

Request For Report Customization @

Key Players

• 1ST Biotherapeutics Inc
• 2N Pharma ApS
• 3Z ehf
• 4D Pharma Plc
• Abaxys Therapeutics SA
• AbbVie
• Abfero Pharmaceuticals Inc
• ABL Bio Inc
• AC Immune SA
• Accure Therapeutics SL
• AceLink Therapeutics Inc
• Acelot Inc
• AcureX Therapeutics Corp
• Addex Pharma SA
• Adhera Therapeutics Inc
• Adicet Bio Inc
• Aeterna Zentaris Inc
• AevisBio Inc
• AgoneX Biopharmaceuticals Inc
• Akome Biotech Ltd
• Alan Laboratories Inc
• Alar Pharmaceuticals Inc
• Alector Inc
• Alexza Pharmaceuticals Inc
• Alkahest Inc
• Alsonex Pty Ltd
• Alterity Therapeutics Ltd
• AltPep Corp
• AlzeCure Pharma AB
• Amathus Therapeutics Inc
• Amneal Pharmaceuticals LLC
• Anavex Life Sciences Corp
• ANLBio Co Ltd
• Annovis Bio Inc
• ApoPharma Inc
• Appello Pharmaceuticals Inc
• Aprinoia Therapeutics Inc
• AptaBio Therapeutics Inc
• Aptamer Sciences Inc
• Aptinyx Inc
• ArmaGen Inc
• Arrien Pharmaceuticals LLC
• Artizan Biosciences Inc
• Arvinas Inc
• Asceneuron SA
• Asdera LLC
• Asha Therapeutics LLC
• Ashvattha Therapeutics LLC
• Asklepios BioPharmaceutical Inc
• Aspen Neuroscience Inc
• AstraZeneca
• Astrogen Ltd
• Atalanta Therapeutics Inc
• Athira Pharma Inc
• Atlantic Healthcare Plc
• AUM LifeTech Inc
• Autifony Therapeutics Ltd
• Avanir Pharmaceuticals Inc
• Axial Therapeutics Inc
• Azymus Therapeutics Inc
• B&A Therapeutics
• Beech Tree Labs Inc
• Belief Biomed Inc
• BenevolentAI Bio
• Berg LLC
• Bial â€" Portela & Ca SA
• BioArctic AB
• Bioasis Technologies Inc
• Biogen
• Bio-Modeling Systems SAS
• Bio-Pharm Solutions Co Ltd
• BioVie Inc
• Bisichem Co Ltd
• BlackThorn Therapeutics Inc
• Blue Therapeutics Inc
• BlueRock Therapeutics
• BrainEver SAS
• BrainStorm Cell Therapeutics Inc
• BrainX Corp
• Bukwang Pharmaceutical
• Cantabio Pharmaceuticals Inc
• Caraway Therapeutics Inc
• Casma Therapeutics Inc
• Celavie Biosciences LLC
• Celeris Therapeutics Inc
• Cellivery Therapeutics Inc
• Celon Pharma SA
• Celros Biotech Co Ltd
• Cerecin Pte Ltd
• Ceregene
• Cerevance
• Cerevel Therapeutics
• CHA Biotech Co Ltd
• Chase Therapeutics Inc
• Chimerna Therapeutics Inc
• Circadian Therapeutics
• Clene Nanomedicine
• Clexio Biosciences Ltd
• Cognition Therapeutics Inc
• Collaborative Medicinal Development LLC
• Contera Pharma ApS
• CuraSen Therapeutics Inc
• Cure Parkinson
• Curemark LLC
• CuroNZ Ltd
• Cypralis Ltd
• Denali Therapeutics
• Diffusion Pharmaceuticals Inc
• Dong-A ST Co Ltd
• Easywell Biomedical Inc
• EHL Bio Co Ltd
• Eikonoklastes Therapeutics Inc
• Eisai Co Ltd
• Eli Lilly and Co
• EmendoBio Inc
• Emerald Health Sciences Inc
• Enterin Inc
• Enveda Biosciences Inc
• E-scape Bio Inc
• Exegenesis Bio Inc
• F Hoffmann-La Roche AG
• FibroGenesis LLC
• Forest Hills Partners Hong Kong Ltd
• Gain Therapeutics
• Gateway Institute for Brain Research
• GB Sciences Inc
• Genervon Biopharmaceuticals LLC
• Glaceum Inc
• GraySpace Therapeutics Inc
• Grespo AB
• Guangzhou Dazhou Biomedicine
• Guangzhou Henovcom Bioscience Co Ltd
• H Lundbeck A/S
• Halia Therapeutics Inc
• Help Therapeutics
• Herantis Pharma Plc
• Hillhurst Biopharmaceuticals Inc
• Hope Biosciences
• Hopstem Biotechnology LLC
• Ibex Biosciences LLC
• ICB International Inc
• Icure Pharmaceutical Inc
• Ildong Pharmaceutical Co Ltd
• Il-Yang Pharm Co Ltd
• Impel Pharmaceuticals Inc
• Imstem Biotechnology Inc
• Inhibikase Therapeutics
• Innervace Inc
• InnoMedica Holding AG
• InnoMedica Schweiz AG
• Integrative Research Laboratories AB
• International Stem Cell Corp
• Intra-Cellular Therapies Inc
• Ionis Pharmaceuticals Inc
• iRegene Therapeutics Co Ltd
• Jeil Pharmaceutical Co Ltd
• Kainos Medicine Inc
• Kallyope Inc
• Kariya Pharmaceuticals IVS
• KeifeRx LLC
• Kissei Pharmaceutical Co Ltd
• Kyowa Kirin Co Ltd
• Lauren Sciences LLC
• Lead Discovery Center GmbH
• LISCure Biosciences Co Ltd
• Living Cell Technologies
• Luye Pharma Group
• Lys Therapeutics SAS
• MD Healthcare Inc
• MeiraGTx Holdings Plc
• Mercaptor Discoveries Inc
• MetiMedi Pharmaceuticals Co Ltd
• MimeTech Srl
• Minerva Neurosciences Inc
• Mission Therapeutics Ltd
• Mitochon Pharmaceuticals Inc
• MitoImmune Therapeutics Inc
• Mitokinin LLC
• Modag
• MThera Pharma Co Ltd
• Muna Therapeutics ApS
• Nanomerics Ltd
• Netherlands Translational Research Center BV
• NeuExcell Therapeutics Inc
• Neuraly Inc
• Neuramedy Co Ltd
• Neuren Pharmaceuticals Ltd
• NeuroDerm Ltd
• Neurodon LLC
• Neurolixis
• Neuron23 Inc
• Neurona Therapeutics Inc
• NeuroNascent Inc
• NeuroPn Therapeutics LLC
• Neuropore Therapies Inc
• NeuroSense Therapeutics Ltd
• Neuvivo Inc
• New World Laboratories Inc
• Newron Pharmaceuticals SPA
• Nexmos Inc
• Nine Square Therapeutics Inc
• NLS Pharmaceutics AG
• Nobilis Therapeutics Inc
• Nostrum Biodiscovery SL
• Novartis AG
• Novo Nordisk AS
• NTZ Lab Ltd
• Nuravax Inc
• NurrOn Pharmaceuticals
• NysnoBio LLC
• Omeros Corp
• Oncodesign SA
• Oxyrane Belgium NV
• Parkure Ltd
• Pharma Two B
• PharmaKure Ltd
• PharmaTher Holdings Ltd
• PharmatrophiX Inc
• Pharmaxis Ltd
• Phoenix Biotechnology Inc
• Pike Therapeutics Inc
• PolyCore Therapeutics LLC
• Praxis Precision Medicines Inc
• Prazer Therapeutics
• PRG S&Tech Inc
• Priavoid GmbH
• Prilenia Therapeutics Development Ltd
• Primary Peptides Inc
• Proclara Biosciences Inc
• Progenra Inc
• Prosetta Biosciences Inc
• Psy Therapeutics Inc
• PureIMS BV
• Revalesio Corp
• Reviva Pharmaceuticals Inc
• Sage Therapeutics Inc
• Samus Therapeutics Inc
• SanBio Co Ltd
• Sangamo Therapeutics
• Saniona AB
• Sanofi
• SBiomedics Co Ltd
• SciNeuro Pharmaceuticals
• SeaBeLife Spas
• Seelos Therapeutics Inc
• Seneb BioSciences Inc
• Serina Therapeutics
• Shanghai Green Valley Pharmaceutical Co Ltd
• Shanghai iCELL Biotechnology Co Ltd
• Shanghai Leado Pharmaceutical Technology Co Ltd
• Shanghai WD Pharmaceutical Co Ltd
• Shape Therapeutics Inc
• Shijiazhuang Yiling Pharmaceutical Co Ltd
• Silver Creek Pharmaceuticals Inc
• Sinfonia Biotherapeutics Inc
• Sinopia Biosciences Inc
• Sio Gene Therapies Inc
• SOLA Biosciences LLC
• Sorrento Therapeutics Inc
• SQZ Biotechnologies Co
• Stealth BioTherapeutics Corp
• Stellate Therapeutics Inc
• Sumitomo Pharma Co Ltd
• Sun Pharma Advanced Research Company Ltd
• Sunovion
• Sunshine Lake Pharma Co Ltd
• Supernus Pharmaceuticals Inc
• Synaptogenix Inc
• Synthonics Inc
• Taiwan Mitochondrion Applied Technology Co Ltd
• Takeda Pharmaceutical Co Ltd
• TauRx Therapeutics Ltd
• Techfields Pharma Co Ltd
• TechnoPhage SA
• Teikoku Pharma USA Inc
• Tessara Therapeutics Pty Ltd
• Teva Pharmaceutical Industries Ltd
• Therapeutic Solutions International Inc
• Trailhead Biosystems Inc
• Tranquis Therapeutics Inc
• TreeFrog Therapeutics SAS
• Treventis Corp
• UCB Biopharma SRL
• UniQure NV
• United Neuroscience Ltd
• Vanda Pharmaceuticals
• Vanqua Bio Inc
• Verge Genomics
• Vincere Biosciences Inc
• Vistagen Therapeutics Inc
• Vitro Biopharma Inc
• Vivifi Biotech Ltd
• Vivozon Inc
• Voyager Therapeutics Inc
• Vyant Bio Inc
• Whan In Pharm Co Ltd
• Wren Therapeutics Ltd
• XellSmart Biomedical (Shanghai) Co Ltd
• Xoc Pharmaceuticals
• XWPharma
• Yuhan Corp
• Yumanity Therapeutics Inc
• Zhittya Genesis Medicine Inc
• ZyVersa Therapeutics

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
Phone: +1-833-761-1700

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Managing Parkinson's: Drug Pipeline Landscape (2023-2033) here

News-ID: 3331771 • Views:

More Releases from Global Insight Services

U.S. and Colorado RTD Cocktail Market Overview by Rising Demands and Scope 2024 to 2033
U.S. and Colorado RTD Cocktail Market Overview by Rising Demands and Scope 2024 …
Market Definition An RTD cocktail is a pre-mixed alcoholic beverage that is typically sold in a can or bottle. RTD cocktails are convenient because they require no additional mixing or preparation, making them ideal for parties or other events where alcohol will be served. There are a variety of RTD cocktails available, including popular options such as Moscow Mules, Margaritas, and Bloody Marys. RTD cocktails are typically made with lower-quality alcohol,
Space Semiconductor Market Booming Across the Globe by Growth, Segments and Forecast 2033
Space Semiconductor Market Booming Across the Globe by Growth, Segments and Fore …
Market Definition A space semiconductor is a type of semiconductor device that is designed to function in extreme conditions found in outer space. Space semiconductors must be able to withstand high levels of radiation and extreme temperatures, as well as the vacuum of space. Space semiconductors are used in a variety of space-based applications, including satellites, spacecraft, and telescopes. They are also used in space exploration missions, such as the Mars
E-passport Market A Deep Dive Into Market Size, Share, And Trends By 2033 | Mühlbauer Group, Primekey Solutions Ab, Thales Group, Safran
E-passport Market A Deep Dive Into Market Size, Share, And Trends By 2033 | Müh …
Market Definition The E-passport Market represents a transformative shift in travel documentation, offering enhanced security and efficiency compared to traditional passports. Also known as biometric passports, E-passports incorporate a microprocessor chip containing the holder's biometric information, such as fingerprints and facial recognition data, along with personal details. This technology not only mitigates the risk of identity theft and fraud but also expedites border control processes by enabling automated authentication. Market Outlook The E-passport
Oligonucleotide Synthesis Market Share, Size 2024 Global Comprehensive Research Study, Trends, Development Status, Opportunities, Future Plans, Competitive Landscape And Growth By Forecast 2033
Oligonucleotide Synthesis Market Share, Size 2024 Global Comprehensive Research …
Market Definition The Oligonucleotide Synthesis Market is a vital component in the biotechnology and pharmaceutical industries, providing customized strands of DNA or RNA sequences for various applications such as genetic research, diagnostics, and therapeutic development. This market encompasses a range of synthesis technologies, including solid-phase synthesis and enzymatic methods, allowing researchers to tailor oligonucleotides with precision. As advancements in genomics, personalized medicine, and synthetic biology drive demand for high-quality oligonucleotides, the

All 5 Releases

More Releases for Therapeutic

The global home therapeutic equipment market is projected to grow from USD 11.06 billion in 2018 to USD XX.XX billion by 2030, at a CAGR of 5.5% during the forecast period. The growth of this market can be attributed to the increasing prevalence of chronic diseases, the rising geriatric population, and the growing demand for home healthcare services. Get free copy of the report 2022: This report studies the Home Therapeutic
Recombinant Therapeutic Antibodies and Proteins Market continues to expand with …
Recombinant therapeutic protein drugs are an important class of medicines, which helps patients in need of novel therapies. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, inflammation/autoimmunity, genetic disorders, and exposure to infectious agents. The latest advancements in protein-engineering technologies have allowed drug manufacturers and developers to adjust desirable functional characteristics of proteins of interest maintaining product efficacy. Protein-based therapies
Therapeutic Vaccine Market 2020 - 2028 Top Companies Agenus Inc., Argos Therapeu …
This detailed market study covers therapeutic vaccine market growth potentials which can assist the stake holders to understand key trends and prospects in therapeutic vaccine market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The
Central Nervous System (CNS) Therapeutic Market Central Nervous System (CNS) The …
MARKET INTRODUCTION The central nervous system (CNS) is the control panel of the body, which is responsible for cognition, movement, senses and emotions. Central nervous system diseases, is a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS). The CNS diseases include neurodegenerative diseases, neurodevelopmental diseases and traumatic injuries. Drugs such as analgesics, anesthetics, nervous system
Therapeutic Vaccines Market Insights by Top Players Novartis AG, GlaxoSmithKline …
Vaccine is a biological product that initiates stimulation to antibodies and helps provide immunity against infectious and chronic diseases. There are various types of vaccines such as inactivated vaccines, subunit vaccines, recombinant vector vaccines and DNA vaccines. Vaccines are mainly prophylactic in nature along with therapeutic effect. The wide application of vaccines is expected to favor the therapeutic vaccines market. Therapeutic vaccine is a combination of biologics that is designed
Therapeutic Socks Market
Therapeutic Socks Market Overview Compression therapy is a safe and cost-effective method of treating wounds, vein thrombosis, phlebitis and providing post-surgery care. It relies on a simple yet efficient principle – applying an elastic garment around a limb. A relatively new form of treatment, it is anticipated to post rapid growth during the next decade. Compression therapy includes garments like leggings, shirts, socks and stockings. The therapeutic socks market, otherwise known